Screener
Charles River Laboratories CRL Acquisition of redeemable noncontrolling interest
Acquisition of redeemable noncontrolling interest at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept crl:RedeemableNoncontrollingInterestIncreaseFromAcquisition.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Redeemable Noncontrolling Interests | Common stock / Shares | Common stock / Amount | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Treasury Stock / Shares | Treasury Stock / Amount | Total Equity Attributableto Common Shareholders | Noncontrolling Interest | Total Equity |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustment of redeemable noncontrolling interests to redemption value | (5,694) | — | — | 5,694 | — | — | — | — | 5,694 | — | 5,694 |
| Purchase of remaining equity interest of Vital River redeemable noncontrolling interest | (24,148) | — | — | — | — | — | — | — | — | — | — |
| Gain on purchase of remaining equity interest of Vital River redeemable noncontrolling interest | (1,151) | — | — | 1,151 | — | — | — | — | 1,151 | — | 1,151 |
| Acquisition of redeemable noncontrolling interest | 45,374 | — | — | — | — | — | — | — | — | — | — |
| Issuance of stock under employee compensation plans | — | 499 | 5 | 25,592 | — | — | — | — | 25,597 | — | 25,597 |
| Purchase of treasury shares | — | — | — | — | — | — | 105 | (24,155) | (24,155) | — | (24,155) |
| Retirement of treasury shares | — | (105) | (1) | (3,847) | (20,307) | — | (105) | 24,155 | — | — | — |
| Stock-based compensation | — | — | — | 72,048 | — | — | — | — | 72,048 | — | 72,048 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's acquisition of redeemable noncontrolling interest?
- Charles River Laboratories (CRL) reported acquisition of redeemable noncontrolling interest of $11.34M in Q4 2023.
- What does acquisition of redeemable noncontrolling interest mean?
- The increase in redeemable noncontrolling interest liability resulting from the acquisition of additional equity interests in a subsidiary that are subject to redemption features.
Ask your AI about Charles River Laboratories's acquisition of redeemable noncontrolling interest.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude